16
Participants
Start Date
October 31, 2005
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
Pioglitazone
placebo-controlled, randomized, cross-over study was to explore the effects of pioglitazone (45 mg q.d. for 6 weeks) on the renal, hormonal and blood pressure responses to changes in sodium intake in a population prone to insulin resistance
Metformin
placebo-controlled, randomized, cross-over study was to explore the effects of pioglitazone (45 mg q.d. for 6 weeks) on the renal, hormonal and blood pressure responses to changes in sodium intake in a population prone to insulin resistance
Pechère-Bertschi Antoinette, Geneva
University of Lausanne Hospitals
OTHER
University Hospital, Geneva
OTHER